Radiosensitivity index emerges as a potential biomarker for combined radiotherapy and immunotherapy
Abstract In the era of immunotherapy, there lacks of a reliable genomic predictor to identify optimal patient populations in combined radiotherapy and immunotherapy (CRI). The purpose of this study is to investigate whether genomic scores defining radiosensitivity are associated with immune response...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-06-01
|
Series: | npj Genomic Medicine |
Online Access: | https://doi.org/10.1038/s41525-021-00200-0 |